Laurence Marton is Director of RenovoRx, Inc.. Currently has a direct ownership of 66,164 shares of RNXT, which is worth approximately $66,164. The most recent transaction as insider was on May 02, 2025, when has been sold 20,480 shares (Common Stock) at a price of $0.15 per share, resulting in proceeds of $3,072. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 66.2K
96.72% 3M change
96.72% 12M change
Total Value Held $66,164

Laurence Marton Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 02 2025
BUY
Exercise of conversion of derivative security
$3,072 $0.15 p/Share
20,480 Added 23.64%
66,164 Common Stock
Apr 08 2025
BUY
Open market or private purchase
$10,242 $0.85 p/Share
12,050 Added 20.87%
45,684 Common Stock
Jan 26 2024
BUY
Open market or private purchase
-
8,196 Added 19.59%
33,634 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$43,244 $1.7 p/Share
25,438 Added 50.0%
25,438 Common Stock
LM

Laurence Marton

Director
Los Altos, CA

Track Institutional and Insider Activities on RNXT

Follow RenovoRx, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RNXT shares.

Notify only if

Insider Trading

Get notified when an Renovo Rx, Inc. insider buys or sells RNXT shares.

Notify only if

News

Receive news related to RenovoRx, Inc.

Track Activities on RNXT